With offices in Shanghai; Cambridge, Massachusetts; and Reykjavik, WuXi NextCODE offers uniquely comprehensive and integrated capabilities for using the genome to improve health. These include a full range of sequencing through our CAP- and CLIA-certified laboratory; the world's most proven and scalable platform for linking genome variation with phenotypes, for population genomics, clinical diagnostics and applications, and scientific wellness; along with a growing portfolio of tests and scans optimized for the China market. All of this is built on the only data architecture built for genomes, making it possible to query, manage, store and share massive genomic data with unrivalled speed and efficiency, in full resolution, online, worldwide.